Does APREMILAST Cause Product dose omission issue? 4,460 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,460 reports of Product dose omission issue have been filed in association with APREMILAST (Otezla). This represents 3.3% of all adverse event reports for APREMILAST.
4,460
Reports of Product dose omission issue with APREMILAST
3.3%
of all APREMILAST reports
2
Deaths
81
Hospitalizations
How Dangerous Is Product dose omission issue From APREMILAST?
Of the 4,460 reports, 2 (0.0%) resulted in death, 81 (1.8%) required hospitalization, and 3 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 4,460 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
GOLIMUMAB (4,216)
Which APREMILAST Alternatives Have Lower Product dose omission issue Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA